Peptide Nasal Sprays: Formulation Limits, Per-Actuation Maths and Storage

A research peptide nasal spray is nothing more than a solution of defined concentration in a metered-pump bottle, and the specification that matters is not the total peptide mass printed on the label but the mass each actuation releases: concentration times the pump's fixed volume. Sprays are used in research because the nasal mucosa is thin, densely vascularised and sits next to olfactory and trigeminal pathways, making it the usual non-parenteral choice in intranasal delivery studies. Below we cover how these formulations are constructed, what restricts which peptides can be sprayed, how to compute per-actuation mass, and how liquid sprays age compared with lyophilized vials. Everything here concerns laboratory reference preparations.

The rationale for the intranasal route

Swallowed peptides meet gastric acid plus pancreatic and brush-border peptidases, and whatever survives is then subject to hepatic first-pass metabolism; measured oral bioavailability for unmodified peptides usually falls well below 1%, the problem examined in oral peptides, capsules and troches. By contrast the nasal cavity presents about 150 cm² of thin, well-perfused epithelium with much lower proteolytic activity and no portal drainage. Published intranasal studies with small peptides report bioavailability anywhere from a few percent up to the low tens of percent depending on molecule and formulation: a huge gain over oral delivery, though still well short of injection.

Anatomy supplies the second reason. Since the 1990s, rodent and non-human primate studies have reported that material deposited on the olfactory epithelium can travel along perineural spaces of the olfactory and trigeminal nerves into cerebrospinal fluid and brain tissue, seemingly circumventing the blood-brain barrier. That body of work explains why nootropic sequences dominate our nasal peptide sprays range: Semax, Selank and similar compounds are precisely the ones for which a direct nose-to-brain route is the research question. The mechanism is still contested and the human evidence sparse, so describe it as reported rather than established.

Constraints on sprayable peptides

• Size. Nasal absorption drops sharply beyond roughly 1,000 Da. Semax (813.93 Da) and Selank (751.89 Da) fall below that line whereas a 4,113 Da GLP-1 analogue does not, which is why sprayed formats in the catalogue tend to be small molecules.
• Volume. Only around 100-150 µL stays in the nasal cavity before the rest runs off, so metered pumps are designed around a 0.1 mL stroke. Raising delivered mass therefore means raising concentration, never volume.
• Mucociliary clearance. Whatever is deposited gets swept toward the nasopharynx in about 15-20 minutes, which caps residence time whatever the formulation.
• Stability in water. A spray is an aqueous solution sitting at room temperature for weeks, so sequences carrying methionine, cysteine or Asn-Gly motifs are the ones most prone to oxidation, disulfide scrambling or deamidation across that period.

Inside the bottle

Permeation enhancers such as chitosan, cyclodextrins and bile-salt derivatives run throughout the intranasal literature and can multiply measured absorption several times over, but they also increase epithelial irritation in tissue models, so they belong to formulation studies rather than to a general-purpose research spray.

Working out what each stroke delivers

Our nasal spray reconstitution kit provides an empty 15 mL metered bottle along with buffered diluent, leaving the arithmetic to you.

1. Set the concentration. Transferring a 10 mg peptide vial into 10 mL of diluent yields 10 ÷ 10 = 1 mg/mL, which is 1,000 mcg/mL.
2. Multiply by pump volume. With 0.1 mL per actuation, each stroke supplies 0.1 × 1,000 = 100 mcg.
3. Work out the actuation count. 10 mL ÷ 0.1 mL gives 100 theoretical strokes, minus 3-5 spent on priming and the 0.5-1 mL of unrecoverable residue beneath the dip tube. Budget for around 85-90 usable actuations rather than 100.
4. Vary one parameter. Putting the same 10 mg vial into 5 mL produces 2 mg/mL and 200 mcg per stroke, with roughly 42 usable actuations. Halving the volume doubles delivered mass and halves how long the bottle lasts in use.

The mg/mL arithmetic used for injectable stocks works identically here, and the reconstitution calculator will handle it if you enter the bottle volume where a vial diluent volume would go. To avoid assembling components yourself, the nasal spray DIY kit combines a 10 mg Semax vial with bottle and solution.

Checking the pump instead of trusting it

Metered pumps are rated at 0.1 mL, yet individual units drift, and an unprimed pump releases air or part of a stroke for its first few actuations. The laboratory check is gravimetric: prime five times, then fire ten strokes into a tared weighing boat and divide. Aqueous solutions are near enough to 1 g/mL that a 1.0 g gain across ten strokes confirms 0.1 mL each. Run the check again once the bottle is about two-thirds empty, since delivered volume declines as the dip tube begins pulling air.

How the liquid format ages

A lyophilized vial is dry solid, stable for years if kept frozen and dark. A spray is the reverse: aqueous, at ambient temperature, with an opening and no septum. Every relevant degradation route for peptides, whether hydrolysis, deamidation, oxidation of methionine, disulfide exchange or adsorption onto the container wall, proceeds faster in solution.

• Keep sealed, unopened sprays at 2-8 °C and let them reach room temperature before actuating, because cold solution is more viscous and delivers a different volume.
• Refrigeration remains preferable once a bottle is in use. Preserved formulations survive room temperature, but the limiting component is the peptide, not the preservative.
• Never freeze an assembled spray. Ice formation concentrates solutes at the freeze front and can split the pump body; freeze-thaw damage to peptide solutions is discussed in how to store peptides.
• Store bottles upright and away from light, since tryptophan and tyrosine residues are photolabile, which is why amber or opaque containers exist.
• Regard an in-use bottle as having a working life measured in weeks rather than months, and mark it with the date it was prepared. Vial labels and log sheets fold that record into the workflow instead of leaving it to memory.

Frequent errors

• Treating the label mass as the delivered mass. A 10 mg bottle does not release 10 mg per stroke; it releases concentration × 0.1 mL.
• Forgetting priming losses when estimating how many actuations a bottle yields.
• Making up a spray with plain bacteriostatic water, which is sterile and preserved but unbuffered and hypotonic, leaving pH and tonicity uncontrolled; buffered nasal diluent exists precisely for this.
• Assuming a large peptide can be sprayed. Past roughly 1,000 Da, absorption in published models falls so far that a spray becomes a delivery study rather than a delivery method.

More on formats, shelf life and shipping is gathered in the nasal spray FAQ.